# OnCo record nct06819215 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06819215/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06819215", "NCT06819215" ;
  schema:name "Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors"@en ;
  schema:description "A phase 1/2 trial of VB15010 in ovarian cancer, prostate cancer, pancreatic ductal adenocarcinoma, biliary tract cancer and colorectal cancer, run by Zhejiang Yangli Pharmaceutical Technology Co., Ltd., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06819215/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06819215> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2024-10-30" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/cholangiocarcinoma/>, <https://onco.cc/cancers/colorectal/> ;
  onco:drugs <https://onco.cc/drugs/vb15010/> .